ProPharma Group

What ProPharma Group does

ProPharma Group is a privately held, PE-backed life sciences consulting firm founded in 2001 and headquartered in the United States, operating 20+ offices across North America, Europe, and Asia Pacific. The firm provides an integrated suite of professional services spanning the full product lifecycle for pharmaceutical, biotechnology, and medical device companies, including Regulatory Sciences (FDA and EMA consulting, expert witness, advertising and promotional review, market access), CRO Services (full-service clinical research, biostatistics, medical writing), Quality and Compliance (GxP auditing, computer system validation, inspection readiness), Pharmacovigilance (clinical and post-marketing safety, QPPV, signal management), Medical Information (24/7 contact centers with multilingual adverse event intake), Functional Service Provider (FSP) Solutions, and Digital Transformation consulting.

The business operates as an enterprise B2B professional services firm, monetizing primarily through project-based and retainer engagements priced under quote-based terms. ProPharma leverages a technology stack that includes proprietary pharmacovigilance safety systems, regulatory intelligence platforms, and AI-enabled compliance analytics layered atop its consulting practice, with recent expansion into QA/AI & ML Quality Compliance Services and a dedicated Cell & Gene Therapy consulting practice. Customer segments are concentrated in three verticals — pharmaceuticals, biotechnology, and medical devices — with named enterprise logos including AstraZeneca, Bayer, Biohaven, Azurity Pharmaceuticals, and Lyell Immunopharma.

Since 2021, ProPharma has executed a substantial inorganic growth strategy under Odyssey Investment Partners' ownership, merging with The Planet Group and acquiring Pharmica Consulting, iSafety Systems, Diamond Pharma Services, M Squared Associates, OneSource Regulatory, Kateric, Digital Lab Consulting, and Clinres Farmacija, materially expanding geographic reach, medical device capability, digital expertise, and European clinical services. The combined entity differentiates through what it describes as the largest global bench of former FDA officials, a 99%+ FDA submission success rate over 15 years, and an integrated one-vendor service model spanning pre-clinical through post-marketing obligations.

Name

ProPharma Group

Legal name

ProPharma Group Holdings, LLC

Website

https://propharmagroup.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

251–500 employees

Short description

ProPharma Group is a privately held, PE-backed life sciences consulting firm providing integrated regulatory, clinical, pharmacovigilance, quality, and medical information services to pharmaceutical, biotechnology, and medical device companies across 20+ global offices.

Ownership category

akta.pro rank

Product category

Life Sciences Regulatory and Pharmacovigilance Consulting

NAICS

Scientific Research and Development Services (5417), Human Resources Consulting Services (541612)

SIC

Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH)

akta.pro secondary industries

Pharmacovigilance, Drug Safety & Risk Management FSP (HLAGAOAF), Regulatory Affairs & Submissions FSP (HLAGAOAD), Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE), Medical Writing & Clinical Documentation FSP (HLAGAOAC), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Regulatory affairs consulting
• Pharmacovigilance services
• Clinical research organization
• Medical information services
• Quality compliance consulting

Headquarters

HQ city

Overland Park

HQ country

United States

HQ region

North America

Offices23 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Regulatory Sciences Consulting: Professional consulting services for FDA, EMA, and other regulatory agency interactions including strategy development, submission support, FDA meetings, and regulatory operations.
2. CRO Services: Clinical research organization services including full-service CRO, site and patient services, biostatistics, and programming for multi-phase clinical development.
3. Pharmacovigilance Services: Clinical and post-marketing pharmacovigilance, safety systems, QPPV/LPPV services, signal management, and periodic safety reports for drugs, biologics, and medical devices.
4. Quality and Compliance Consulting: GxP compliance, auditing, computer system validation, inspection readiness, and quality assurance services.
5. Medical Information Services: Global contact center support, adverse event intake, medical communications, and patient support services with 24/7/365 availability.
6. FSP Solutions: Functional service provider solutions offering clinical operations, data sciences, biostatistics, medical writing, and decentralized clinical trials as an extension of client teams.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

ProPharma Group is a life sciences consulting firm providing an integrated suite of regulatory, clinical, quality/compliance, pharmacovigilance, medical information, and digital transformation services to pharmaceutical, biotechnology, and medical device companies throughout the product lifecycle. Services are delivered by expert consultants — many of whom are former FDA officials — operating through direct enterprise engagements, with 20+ global offices supporting FDA/EMA submissions, clinical research, safety monitoring, and compliance programs. Revenue is driven by professional service fees and functional service provider (FSP) managed service arrangements.

Product overview

ProPharma Group is a life sciences consulting firm offering an integrated suite of services across the full product lifecycle. The core offerings include Regulatory Sciences (FDA and European regulatory consulting, expert witness services, advertising & promotional review, market access strategy), CRO Services (full-service clinical research, site & patient services, biostatistics), Quality & Compliance (validation, auditing, inspection readiness), Pharmacovigilance Solutions (clinical and post-marketing PV, safety systems, QPPV services), Medical Information (contact centers, adverse event intake, medical communications), FSP Solutions (flexible staffing for clinical operations, data sciences, biostatistics), and Digital Transformation (technology consulting, data strategy, validation services). These services work together as an integrated unit, with specialized service lines operating independently while seamlessly collaborating to support global pharmaceutical, biotechnology, and medical device companies from early development through clinical, regulatory approval, and commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Sciences Comprehensive regulatory sciences consulting services supporting the full lifecycle for drugs, biologics, medical devices, and diagnostics, offering pre- and post-approval support for FDA, EMA, and national competent authorities. Includes FDA regulatory consulting, FDA meeting preparation, expert witness services, European regulatory development, MAH partnerships, advertising and promotional review, market access strategy, and medical device solutions.
• CRO Services Clinical research organization services providing multi-phase clinical development and study execution for drugs, biologics, medical devices, and diagnostics through a global team of trusted experts. Includes full-service CRO, site and patient services, biostatistics and programming, global medical writing and transparency, and dedicated medical device clinical operations.
• Quality & Compliance Quality and compliance consulting services applying project management methodologies to help clients develop and launch products to market, with consulting services ensuring quality, compliance, efficiency, and safety throughout the full lifecycle. Includes computer system validation, GxP compliance and auditing, QA/AI & ML compliance services, inspection readiness, commissioning/qualification/validation, clinical quality assurance, healthcare compliance services, and cell and gene therapy consulting.
• Pharmacovigilance Solutions Full suite of pharmacovigilance solutions ensuring safety and consistency from clinical development through post-approval, including clinical and post-marketing pharmacovigilance, safety systems, QPPV/LPPV services, case management, signal management, periodic safety reports and risk management plans, global ICSR submissions, global literature review, and regulatory intelligence.
• Medical Information Medical information services with strategically positioned contact centers providing adverse event intake, medical writing, content management, promotional review, and extended medical information services supporting companies of all sizes. Includes global contact center support, product complaint intake and follow-up, patient support and commercial services, medical communications/content management/translation, animal health services, REMS/RMP support, and consumer health services.
• FSP Solutions Functional service provider solutions delivering flexible staffing as an extension of internal research teams, powered by top-tier professionals, proven processes, and tailored oversight across clinical operations, data sciences, biostatistics, medical writing, and decentralized clinical trials.
• Digital Transformation Digital transformation consulting services providing fit-for-purpose technology solutions for pharmaceutical and biotech clients, including digital blueprint, data strategy, technology services, and validation quality and compliance.

Quantifiable outcome

• 99+% successful FDA submission rate over the last 15 years
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered core, major and regional.

• KatericcoreStrategic or Co-development Partner · 1 September 2022Acquired Kateric, a medical writing and clinical trials disclosure support provider. Enhanced ProPharma's medical writing services and broadened global reach across major therapeutic areas.
• OneSource Regulatory (OSR) and OSR-TcoreStrategic or Co-development Partner · 23 August 2022Acquired OneSource Regulatory and OSR-T to expand regulatory consulting and technology solutions. Strengthened ProPharma's position as a global provider for life sciences industry across full product lifecycle.
• M Squared AssociatescoreStrategic or Co-development Partner · 16 March 2022Acquired M Squared Associates, a consulting firm specializing in clinical, regulatory, and quality services for medical devices and diagnostics. Expanded ProPharma's capabilities in medical technology industry.
• Pharmica ConsultingcoreStrategic or Co-development Partner · 6 October 2021Acquired Pharmica Consulting, a life science consulting company specializing in project management solutions and proprietary software for pharmaceutical and biotech companies. The deal enhanced ProPharma's portfolio with software tools and extended global services.
• The Planet GroupmajorStrategic or Co-development Partner · 27 May 2021ProPharma Group and The Planet Group announced a merger to combine their operations, expanding growth opportunities and enhancing service offerings across global life sciences, technology, energy, and engineering sectors. The Planet Group provided specialized consulting and outsourced human capital solutions.
• Diamond Pharma ServicescoreStrategic or Co-development PartnerAcquired Diamond Pharma Services, a leading regulatory sciences, pharmacovigilance, and compliance quality consultancy headquartered in the UK with offices in Europe.
• Digital Lab Consulting (DLC)coreStrategic or Co-development PartnerAcquired Digital Lab Consulting, providing deep industry and digital transformation expertise to enable organizations to transform business through better use of data and technology.
• Clinres FarmacijaregionalStrategic or Co-development PartnerAcquired Clinres Farmacija, a leading CRO based in Croatia, reinforcing ProPharma's commitment to expanding presence in Central and Eastern Europe with comprehensive clinical services.
• Clinres FarmacijaregionalStrategic or Co-development PartnerAcquired Clinres Farmacija, a leading CRO based in Croatia, reinforcing ProPharma's commitment to expanding presence in Central and Eastern Europe with comprehensive clinical services.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Fortrea (formerly Labcorp Drug Development): Fortrea is a public CRO spun out of Labcorp providing clinical, regulatory, and pharmacovigilance services globally. Its mid-to-large CRO positioning overlaps ProPharma's CRO and PV service lines in pharma and biotech client engagements.
• ICON plc: ICON is one of the world's largest CROs offering regulatory, clinical, PV, and FSP services at global scale. While much larger and broader than ProPharma, ICON competes head-to-head for regulatory and pharmacovigilance engagements.
• Syneos Health: Syneos Health is a large biopharmaceutical solutions provider (now private under Elliott/Veritas) offering clinical, commercial, and regulatory services. It competes with ProPharma on clinical and regulatory consulting engagements.
• IQVIA: IQVIA is the largest global CRO with industry-leading regulatory, pharmacovigilance, and clinical operations offerings. Its scale and technology platforms (e.g., Safety System) compete directly with ProPharma's services to large pharma clients.
• Medpace Holdings: Medpace is a publicly traded mid-to-large CRO with strong regulatory and clinical operations services for pharma and biotech. While more focused on clinical execution than PV, it competes for regulatory consulting RFPs in ProPharma's target segments.
• Charles River Laboratories: Charles River is a global CRO and lab services provider offering preclinical, clinical, and regulatory support. It competes with ProPharma particularly on regulatory consulting and clinical research services for pharma and biotech.

Direct peers

• Parexel International: Parexel is a large, PE-backed (EQT/GS) global CRO with deep regulatory, clinical, and pharmacovigilance capabilities, directly competing for the same enterprise pharma clients ProPharma serves across the full product lifecycle.
• MMS Holdings: MMS Holdings is a private, PE-backed (Permira) clinical research and regulatory services firm with strong FSP and pharmacovigilance offerings, directly competing with ProPharma's FSP Solutions and PV service lines.
• Pharmalex: Pharmalex is a private, PE-backed (Bridgepoint) regulatory and compliance consulting firm serving pharma and biotech, with overlapping services in regulatory affairs, pharmacovigilance, and quality—making it ProPharma's closest direct competitor in mid-market life sciences consulting.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size global CRO providing clinical, regulatory, and PV services to pharma and biotech, with a similar positioning to ProPharma in mid-market and specialty therapeutic areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/propharmagroup

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Subsidiaries20 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A10 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ProPharma Group